NIL / BNB

NIL / TRY

NIL / USDC

NIL / USDT

AEUR / USDT

AVNT / TRY

AVNT / USDC

AVNT / USDT

YB / FDUSD

YB / USDT

KDA / BTC

KDA / USDT

LA / FDUSD

PROVE / FDUSD

2Z / BNB

ENA / BNB

MIRA / FDUSD

GALA / BTC

ZBT / BNB

NOM / TRY

LEXUS GRANITO (INDIA) LTD

ONYX BIOTEC LIMITED

MITCON CON & ENG SER LTD

NRB INDUS. BEARINGS LTD.

SONAM LIMITED

KONTOR SPACE LIMITED

SURANI STEEL TUBES LTD.

GENERIC ENG CONS PROJ LTD

LATTEYS INDUSTRIES LTD

DCM NOUVELLE LIMITED

CAPITAL TRUST LTD

PARAMATRIX TECHNOLOGIES L

G-TEC JAINX EDUCATION LTD

BEACON TRUSTEESHIP LTD

ITALIAN EDIBLES LIMITED

QUICKTOUCH TECHNOLOGIES L

JIWANRAM SHEODUTTRA IND L

FUT LIFESTYLE FASH LTD

CEREBRA INT TECH LTD

TARAPUR TRANSFORMERS LTD

Click here to get full coverage on Indoco Remedies Clarifies Market-Driven Volume Surge - TipRanks

Indoco Remedies Clarifies Market-Driven Volume Surge  TipRanks

Indoco Remedies Clarifies Market-Driven Volume Surge - TipRanks

Click here to get full coverage on Acute Respiratory Distress Syndrome Market Forecast and Company Analysis Report 2025-2033 Featuring Ajanta, Akorn, Alembic, Cipla, Indoco Remedies, J&J, Novartis, Ocular Therapeutix, Sun, Teva - Yahoo Finance

Acute Respiratory Distress Syndrome Market Forecast and Company Analysis Report 2025-2033 Featuring Ajanta, Akorn, Alembic, Cipla, Indoco Remedies, J&J, Novartis, Ocular Therapeutix, Sun, Teva  Yahoo Finance

Acute Respiratory Distress Syndrome Market Forecast and Company Analysis Report 2025-2033 Featuring Ajanta, Akorn, Alembic, Cipla, Indoco Remedies, J&J, Novartis, Ocular Therapeutix, Sun, Teva - Yahoo Finance

Click here to get full coverage on Here's Why Shareholders Should Examine Indoco Remedies Limited's (NSE:INDOCO) CEO Compensation Package More Closely - simplywall.st

Here's Why Shareholders Should Examine Indoco Remedies Limited's (NSE:INDOCO) CEO Compensation Package More Closely  simplywall.st

Here's Why Shareholders Should Examine Indoco Remedies Limited's (NSE:INDOCO) CEO Compensation Package More Closely - simplywall.st

Click here to get full coverage on Indoco Remedies Soars 9.36%, Hits Intraday High Amid Market Decline - Markets Mojo

Indoco Remedies Soars 9.36%, Hits Intraday High Amid Market Decline  Markets Mojo

Indoco Remedies Soars 9.36%, Hits Intraday High Amid Market Decline - Markets Mojo

Click here to get full coverage on Indoco Remedies receives USFDA approval for Rivaroxaban Tablets - Business Standard

Indoco Remedies receives USFDA approval for Rivaroxaban Tablets  Business Standard

Indoco Remedies receives USFDA approval for Rivaroxaban Tablets - Business Standard

Click here to get full coverage on Can Indoco Remedies Limited Outperform the Market in a Slowing Economy - Growth Stock Opportunities & Plan Your Exit as You Enter – Risk First - earlytimes.in

Can Indoco Remedies Limited Outperform the Market in a Slowing Economy - Growth Stock Opportunities & Plan Your Exit as You Enter – Risk First  earlytimes.in

Can Indoco Remedies Limited Outperform the Market in a Slowing Economy - Growth Stock Opportunities & Plan Your Exit as You Enter – Risk First - earlytimes.in

Click here to get full coverage on Indoco Remedies secures USFDA approval for Allopurinol Tablets to lower high uric acid levels in blood - Medical Dialogues

Indoco Remedies secures USFDA approval for Allopurinol Tablets to lower high uric acid levels in blood  Medical Dialogues

Indoco Remedies secures USFDA approval for Allopurinol Tablets to lower high uric acid levels in blood - Medical Dialogues

Click here to get full coverage on Sell Indoco Remedies Shares Maintains Dolat Capital Post Q1 Results, Sees 36% Downside — Heres Why - NDTV Profit

Sell Indoco Remedies Shares Maintains Dolat Capital Post Q1 Results, Sees 36% Downside — Heres Why  NDTV Profit

Sell Indoco Remedies Shares Maintains Dolat Capital Post Q1 Results, Sees 36% Downside — Heres Why - NDTV Profit

Click here to get full coverage on Indoco Remedies Limited (NSE:INDOCO) Soars 27% But It's A Story Of Risk Vs Reward - simplywall.st

Indoco Remedies Limited (NSE:INDOCO) Soars 27% But It's A Story Of Risk Vs Reward  simplywall.st

Indoco Remedies Limited (NSE:INDOCO) Soars 27% But It's A Story Of Risk Vs Reward - simplywall.st

Click here to get full coverage on Indoco Remedies gets USFDA nod for venous thromboembolism drug Rivaroxaban - Medical Dialogues

Indoco Remedies gets USFDA nod for venous thromboembolism drug Rivaroxaban  Medical Dialogues

Indoco Remedies gets USFDA nod for venous thromboembolism drug Rivaroxaban - Medical Dialogues

Click here to get full coverage on Indoco Remedies Faces Technical Shift Amid Ongoing Financial Challenges and Declining Profitability - Markets Mojo

Indoco Remedies Faces Technical Shift Amid Ongoing Financial Challenges and Declining Profitability  Markets Mojo

Indoco Remedies Faces Technical Shift Amid Ongoing Financial Challenges and Declining Profitability - Markets Mojo

Click here to get full coverage on Nirmal Bang Remains Structurally Positive On Indoco Remedies; Maintains Hold Rating — Check Target Price - NDTV Profit

Nirmal Bang Remains Structurally Positive On Indoco Remedies; Maintains Hold Rating — Check Target Price  NDTV Profit

Nirmal Bang Remains Structurally Positive On Indoco Remedies; Maintains Hold Rating — Check Target Price - NDTV Profit

Click here to get full coverage on Indoco Remedies gains on receiving USFDA nod for Rivaroxaban tablets - Business Standard

Indoco Remedies gains on receiving USFDA nod for Rivaroxaban tablets  Business Standard

Indoco Remedies gains on receiving USFDA nod for Rivaroxaban tablets - Business Standard

Click here to get full coverage on Earnings Update: Here's Why Analysts Just Lifted Their Indoco Remedies Limited (NSE:INDOCO) Price Target To ₹259 - simplywall.st

Earnings Update: Here's Why Analysts Just Lifted Their Indoco Remedies Limited (NSE:INDOCO) Price Target To ₹259  simplywall.st

Earnings Update: Here's Why Analysts Just Lifted Their Indoco Remedies Limited (NSE:INDOCO) Price Target To ₹259 - simplywall.st

Click here to get full coverage on Indoco Remedies Experiences Technical Shift Amid Ongoing Financial Challenges - Markets Mojo

Indoco Remedies Experiences Technical Shift Amid Ongoing Financial Challenges  Markets Mojo

Indoco Remedies Experiences Technical Shift Amid Ongoing Financial Challenges - Markets Mojo

Click here to get full coverage on Indoco Remedies Subsidiary Launches Generic Drug In UK - NDTV Profit

Indoco Remedies Subsidiary Launches Generic Drug In UK  NDTV Profit

Indoco Remedies Subsidiary Launches Generic Drug In UK - NDTV Profit

Click here to get full coverage on What drove Indoco Remedies share price 6% higher today? Top details inside - Business Standard

What drove Indoco Remedies share price 6% higher today? Top details inside  Business Standard

What drove Indoco Remedies share price 6% higher today? Top details inside - Business Standard

Click here to get full coverage on Indoco Remedies Shows Mixed Technical Trends Amid Market Evaluation Revision - Markets Mojo

Indoco Remedies Shows Mixed Technical Trends Amid Market Evaluation Revision  Markets Mojo

Indoco Remedies Shows Mixed Technical Trends Amid Market Evaluation Revision - Markets Mojo

Click here to get full coverage on Indoco Remedies Faces Mixed Technical Trends Amid Market Volatility and Underperformance - Markets Mojo

Indoco Remedies Faces Mixed Technical Trends Amid Market Volatility and Underperformance  Markets Mojo

Indoco Remedies Faces Mixed Technical Trends Amid Market Volatility and Underperformance - Markets Mojo

Click here to get full coverage on Indoco Remedies Faces Mixed Technical Signals Amid Market Evaluation Revision - Markets Mojo

Indoco Remedies Faces Mixed Technical Signals Amid Market Evaluation Revision  Markets Mojo

Indoco Remedies Faces Mixed Technical Signals Amid Market Evaluation Revision - Markets Mojo

Click here to get full coverage on Indoco Remedies CRO AnaCipher gets one Form 483 from USFDA - Medical Dialogues

Indoco Remedies CRO AnaCipher gets one Form 483 from USFDA  Medical Dialogues

Indoco Remedies CRO AnaCipher gets one Form 483 from USFDA - Medical Dialogues

Click here to get full coverage on USFDA successfully completes inspection at Indoco Remedies Mumbai API facility - Medical Dialogues

USFDA successfully completes inspection at Indoco Remedies Mumbai API facility  Medical Dialogues

USFDA successfully completes inspection at Indoco Remedies Mumbai API facility - Medical Dialogues

Click here to get full coverage on What Valuation Gaps Could Correct in Indoco Remedies Limited Stock Price - Technical Analysis Insights & Hidden Gems with Outstanding Profit Margins - earlytimes.in

What Valuation Gaps Could Correct in Indoco Remedies Limited Stock Price - Technical Analysis Insights & Hidden Gems with Outstanding Profit Margins  earlytimes.in

What Valuation Gaps Could Correct in Indoco Remedies Limited Stock Price - Technical Analysis Insights & Hidden Gems with Outstanding Profit Margins - earlytimes.in

Click here to get full coverage on Indoco Remedies (NSE:INDOCO) shareholder returns have been notable, earning 60% in 5 years - simplywall.st

Indoco Remedies (NSE:INDOCO) shareholder returns have been notable, earning 60% in 5 years  simplywall.st

Indoco Remedies (NSE:INDOCO) shareholder returns have been notable, earning 60% in 5 years - simplywall.st

Click here to get full coverage on Indoco Remedies Faces Mixed Technical Trends Amidst Market Volatility - Markets Mojo

Indoco Remedies Faces Mixed Technical Trends Amidst Market Volatility  Markets Mojo

Indoco Remedies Faces Mixed Technical Trends Amidst Market Volatility - Markets Mojo

Click here to get full coverage on Indoco Remedies rises 6% on EU GMP certificate, trims gains after Q1 show - Business Standard

Indoco Remedies rises 6% on EU GMP certificate, trims gains after Q1 show  Business Standard

Indoco Remedies rises 6% on EU GMP certificate, trims gains after Q1 show - Business Standard

Click here to get full coverage on Indoco receives EU GMP certificate for its sterile manufacturing facility in Goa - Indian Pharma Post

Indoco receives EU GMP certificate for its sterile manufacturing facility in Goa  Indian Pharma Post

Indoco receives EU GMP certificate for its sterile manufacturing facility in Goa - Indian Pharma Post

Click here to get full coverage on Indoco Remedies Experiences Notable Rebound Amid Broader Small-Cap Market Strength - Markets Mojo

Indoco Remedies Experiences Notable Rebound Amid Broader Small-Cap Market Strength  Markets Mojo

Indoco Remedies Experiences Notable Rebound Amid Broader Small-Cap Market Strength - Markets Mojo

Click here to get full coverage on Indoco Remedies Q4 Results: Shares fall 7% as company reports loss, revenue drops 12% - CNBC TV18

Indoco Remedies Q4 Results: Shares fall 7% as company reports loss, revenue drops 12%  CNBC TV18

Indoco Remedies Q4 Results: Shares fall 7% as company reports loss, revenue drops 12% - CNBC TV18

Click here to get full coverage on FDA completes inspection of Indoco’s API manufacturing facility at Patalganga with zero observations - Indian Pharma Post

FDA completes inspection of Indoco’s API manufacturing facility at Patalganga with zero observations  Indian Pharma Post

FDA completes inspection of Indoco’s API manufacturing facility at Patalganga with zero observations - Indian Pharma Post

Click here to get full coverage on Here's why Indoco Remedies shares were under pressure on March 11; details | Markets News - Business Standard

Here's why Indoco Remedies shares were under pressure on March 11; details | Markets News  Business Standard

Here's why Indoco Remedies shares were under pressure on March 11; details | Markets News - Business Standard

Click here to get full coverage on Indoco Remedies gets warning letter from USFDA for Goa plant - The Economic Times

Indoco Remedies gets warning letter from USFDA for Goa plant  The Economic Times

Indoco Remedies gets warning letter from USFDA for Goa plant - The Economic Times

Click here to get full coverage on Indoco Remedies Shows Strong Rebound Amid Broader Small-Cap Market Gains - Markets Mojo

Indoco Remedies Shows Strong Rebound Amid Broader Small-Cap Market Gains  Markets Mojo

Indoco Remedies Shows Strong Rebound Amid Broader Small-Cap Market Gains - Markets Mojo

Click here to get full coverage on Indoco Remedies Faces Continued Financial Challenges Amid Declining Profit Trends - Markets Mojo

Indoco Remedies Faces Continued Financial Challenges Amid Declining Profit Trends  Markets Mojo

Indoco Remedies Faces Continued Financial Challenges Amid Declining Profit Trends - Markets Mojo

Click here to get full coverage on Indoco Remedies shares rise as it receives EU 'Good Manufacturing Practices' certificate - CNBC TV18

Indoco Remedies shares rise as it receives EU 'Good Manufacturing Practices' certificate  CNBC TV18

Indoco Remedies shares rise as it receives EU 'Good Manufacturing Practices' certificate - CNBC TV18

Click here to get full coverage on Indoco Remedies Enters ₹24.65 Crore Sale-Leaseback Deal for Waluj Facility and CRO - scanx.trade

Indoco Remedies Enters ₹24.65 Crore Sale-Leaseback Deal for Waluj Facility and CRO  scanx.trade

Indoco Remedies Enters ₹24.65 Crore Sale-Leaseback Deal for Waluj Facility and CRO - scanx.trade

Click here to get full coverage on Indoco Remedies gets Certificate of EU GMP Compliance for Goa sterile drug product manufacturing facility - Medical Dialogues

Indoco Remedies gets Certificate of EU GMP Compliance for Goa sterile drug product manufacturing facility  Medical Dialogues

Indoco Remedies gets Certificate of EU GMP Compliance for Goa sterile drug product manufacturing facility - Medical Dialogues

Click here to get full coverage on Indoco Remedies Standalone June 2025 Net Sales at Rs 392.53 crore, down 2.22% Y-o-Y - Moneycontrol

Indoco Remedies Standalone June 2025 Net Sales at Rs 392.53 crore, down 2.22% Y-o-Y  Moneycontrol

Indoco Remedies Standalone June 2025 Net Sales at Rs 392.53 crore, down 2.22% Y-o-Y - Moneycontrol

Click here to get full coverage on Indoco Remedies' AnaCipher says USFDA has completed inspection of Hyderabad facility - CNBC TV18

Indoco Remedies' AnaCipher says USFDA has completed inspection of Hyderabad facility  CNBC TV18

Indoco Remedies' AnaCipher says USFDA has completed inspection of Hyderabad facility - CNBC TV18

Click here to get full coverage on Indoco Remedies Faces Mixed Technical Trends Amid Ongoing Market Challenges - Markets Mojo

Indoco Remedies Faces Mixed Technical Trends Amid Ongoing Market Challenges  Markets Mojo

Indoco Remedies Faces Mixed Technical Trends Amid Ongoing Market Challenges - Markets Mojo

Click here to get full coverage on Published on: 2025-10-21 07:28:31 - earlytimes.in

Published on: 2025-10-21 07:28:31  earlytimes.in

Published on: 2025-10-21 07:28:31 - earlytimes.in

Click here to get full coverage on Can Indoco Remedies Limited Maintain Its Growth Rate as a Small Cap - earlytimes.in

Can Indoco Remedies Limited Maintain Its Growth Rate as a Small Cap  earlytimes.in

Can Indoco Remedies Limited Maintain Its Growth Rate as a Small Cap - earlytimes.in

Click here to get full coverage on Indoco Remedies enters into sale and lease back for its movable properties - Business Standard

Indoco Remedies enters into sale and lease back for its movable properties  Business Standard

Indoco Remedies enters into sale and lease back for its movable properties - Business Standard

Click here to get full coverage on What Valuation Gaps Could Correct in Indoco Remedies Limited Stock Price - Economic Data Impact & Use Time as Your Investing Ally - earlytimes.in

What Valuation Gaps Could Correct in Indoco Remedies Limited Stock Price - Economic Data Impact & Use Time as Your Investing Ally  earlytimes.in

What Valuation Gaps Could Correct in Indoco Remedies Limited Stock Price - Economic Data Impact & Use Time as Your Investing Ally - earlytimes.in

Click here to get full coverage on Indoco Remedies reports net loss of ₹35.6 crore in Q1, margin contracts - CNBC TV18

Indoco Remedies reports net loss of ₹35.6 crore in Q1, margin contracts  CNBC TV18

Indoco Remedies reports net loss of ₹35.6 crore in Q1, margin contracts - CNBC TV18

Click here to get full coverage on RGP protests outside Indoco Remedies over out-of-state hiring - The Goan

RGP protests outside Indoco Remedies over out-of-state hiring  The Goan

RGP protests outside Indoco Remedies over out-of-state hiring - The Goan

Click here to get full coverage on Buy Sun Pharma, Cipla; Hold Lupin, Indoco Among Other Pharma Stocks, Says Systematix Ahead Of Q4 Results - NDTV Profit

Buy Sun Pharma, Cipla; Hold Lupin, Indoco Among Other Pharma Stocks, Says Systematix Ahead Of Q4 Results  NDTV Profit

Buy Sun Pharma, Cipla; Hold Lupin, Indoco Among Other Pharma Stocks, Says Systematix Ahead Of Q4 Results - NDTV Profit

Click here to get full coverage on Initiative secures media mandate for Indoco Remedies’ oral care brand Sensodent - Social Samosa

Initiative secures media mandate for Indoco Remedies’ oral care brand Sensodent  Social Samosa

Initiative secures media mandate for Indoco Remedies’ oral care brand Sensodent - Social Samosa

Click here to get full coverage on Indoco Remedies reports standalone net loss of Rs 26.24 crore in the March 2025 quarter - Business Standard

Indoco Remedies reports standalone net loss of Rs 26.24 crore in the March 2025 quarter  Business Standard

Indoco Remedies reports standalone net loss of Rs 26.24 crore in the March 2025 quarter - Business Standard

Click here to get full coverage on Indoco Remedies reports consolidated net loss of Rs 35.79 crore in the June 2025 quarter - Business Standard

Indoco Remedies reports consolidated net loss of Rs 35.79 crore in the June 2025 quarter  Business Standard

Indoco Remedies reports consolidated net loss of Rs 35.79 crore in the June 2025 quarter - Business Standard

Click here to get full coverage on Indoco Remedies Experiences Evaluation Shift Amidst Mixed Technical Indicators and Performance Challenges - Markets Mojo

Indoco Remedies Experiences Evaluation Shift Amidst Mixed Technical Indicators and Performance Challenges  Markets Mojo

Indoco Remedies Experiences Evaluation Shift Amidst Mixed Technical Indicators and Performance Challenges - Markets Mojo

Click here to get full coverage on Indoco Remedies Consolidated June 2025 Net Sales at Rs 437.89 crore, up 1.48% Y-o-Y - Moneycontrol

Indoco Remedies Consolidated June 2025 Net Sales at Rs 437.89 crore, up 1.48% Y-o-Y  Moneycontrol

Indoco Remedies Consolidated June 2025 Net Sales at Rs 437.89 crore, up 1.48% Y-o-Y - Moneycontrol

Click here to get full coverage on Indoco Remedies Awarded EU GMP Certification for Sterile Drug Manufacturing at Goa Plant II - Machine Maker

Indoco Remedies Awarded EU GMP Certification for Sterile Drug Manufacturing at Goa Plant II  Machine Maker

Indoco Remedies Awarded EU GMP Certification for Sterile Drug Manufacturing at Goa Plant II - Machine Maker

Click here to get full coverage on Indoco Remedies arm launches heart attack drug Ticagrelor filmcoated in UK - Medical Dialogues

Indoco Remedies arm launches heart attack drug Ticagrelor filmcoated in UK  Medical Dialogues

INDOCO

Price Chart

Key Statistics

Technicals

About INDOCO

Latest News

Indoco Remedies Clarifies Market-Driven Volume Surge - TipRanks

Acute Respiratory Distress Syndrome Market Forecast and Company Analysis Report 2025-2033 Featuring Ajanta, Akorn, Alembic, Cipla, Indoco Remedies, J&J, Novartis, Ocular Therapeutix, Sun, Teva - Yahoo Finance

Here's Why Shareholders Should Examine Indoco Remedies Limited's (NSE:INDOCO) CEO Compensation Package More Closely - simplywall.st

Advanced Charts

Top Gainers

Top Losers